A detailed history of Legal & General Group PLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 938,668 shares of DGX stock, worth $129 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
938,668
Previous 938,668 -0.0%
Holding current value
$129 Million
Previous $129 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$137.09 - $137.09 $2.87 Million - $2.87 Million
-20,954 Reduced 2.18%
938,668 $129 Million
Q2 2024

Aug 14, 2024

SELL
$125.91 - $144.34 $1.71 Million - $1.95 Million
-13,542 Reduced 1.39%
959,622 $131 Million
Q1 2024

May 14, 2024

SELL
$123.78 - $142.11 $5.94 Million - $6.81 Million
-47,955 Reduced 4.7%
973,164 $130 Million
Q4 2023

Feb 15, 2024

BUY
$120.62 - $141.12 $11.3 Million - $13.3 Million
93,963 Added 10.13%
1,021,119 $141 Million
Q3 2023

Nov 14, 2023

SELL
$121.86 - $144.92 $3.21 Million - $3.82 Million
-26,344 Reduced 2.76%
927,156 $113 Million
Q2 2023

Aug 14, 2023

SELL
$130.56 - $146.84 $238,272 - $267,983
-1,825 Reduced 0.19%
953,500 $134 Million
Q1 2023

May 15, 2023

SELL
$131.53 - $155.76 $13.7 Million - $16.3 Million
-104,476 Reduced 9.86%
955,325 $135 Million
Q4 2022

Feb 14, 2023

SELL
$123.31 - $157.26 $9.49 Million - $12.1 Million
-76,926 Reduced 6.77%
1,059,801 $166 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $12.6 Million - $14.6 Million
-103,316 Reduced 8.33%
1,136,727 $139 Million
Q2 2022

Aug 22, 2022

BUY
$127.07 - $145.39 $7.03 Million - $8.04 Million
55,298 Added 4.67%
1,240,043 $165 Million
Q1 2022

May 16, 2022

BUY
$129.09 - $164.35 $14 Million - $17.9 Million
108,691 Added 10.1%
1,184,745 $162 Million
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $7.87 Million - $9.7 Million
-56,093 Reduced 4.95%
1,076,054 $186 Million
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $4.79 Million - $5.69 Million
36,030 Added 3.29%
1,132,147 $165 Million
Q2 2021

Aug 12, 2021

BUY
$126.66 - $141.48 $7.87 Million - $8.79 Million
62,112 Added 6.01%
1,096,117 $145 Million
Q1 2021

May 17, 2021

BUY
$114.63 - $133.34 $2.95 Million - $3.43 Million
25,750 Added 2.55%
1,034,005 $133 Million
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $3.11 Million - $3.53 Million
27,568 Added 2.81%
1,008,255 $120 Million
Q3 2020

Nov 13, 2020

SELL
$107.05 - $130.01 $900,932 - $1.09 Million
-8,416 Reduced 0.85%
980,687 $112 Million
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $19.3 Million - $32.2 Million
-262,819 Reduced 20.99%
989,103 $113 Million
Q1 2020

May 14, 2020

BUY
$75.14 - $115.68 $5.44 Million - $8.38 Million
72,417 Added 6.14%
1,251,922 $101 Million
Q4 2019

Feb 13, 2020

BUY
$100.29 - $107.99 $1.35 Million - $1.45 Million
13,455 Added 1.15%
1,179,505 $126 Million
Q3 2019

Nov 13, 2019

BUY
$97.85 - $107.42 $516,158 - $566,640
5,275 Added 0.45%
1,166,050 $125 Million
Q2 2019

Aug 14, 2019

BUY
$85.18 - $101.94 $4.93 Million - $5.89 Million
57,827 Added 5.24%
1,160,775 $118 Million
Q1 2019

May 15, 2019

BUY
$80.68 - $89.92 $12.5 Million - $13.9 Million
154,986 Added 16.35%
1,102,948 $99.2 Million
Q4 2018

Feb 15, 2019

BUY
$79.75 - $108.38 $7.9 Million - $10.7 Million
99,115 Added 11.68%
947,962 $78.9 Million
Q3 2018

Nov 20, 2018

BUY
$105.42 - $114.99 $8.14 Million - $8.88 Million
77,204 Added 10.01%
848,847 $91.6 Million
Q2 2018

Aug 10, 2018

SELL
$97.35 - $113.14 $3.29 Million - $3.82 Million
-33,778 Reduced 4.19%
771,643 $84.8 Million
Q1 2018

May 17, 2018

SELL
$96.42 - $107.88 $450,570 - $504,123
-4,673 Reduced 0.58%
805,421 $80.8 Million
Q4 2017

Feb 13, 2018

BUY
$90.86 - $100.24 $73.6 Million - $81.2 Million
810,094
810,094 $79.8 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.